Hormonal contraception and venous thromboembolism

  title={Hormonal contraception and venous thromboembolism},
  author={{\O}. Lidegaard and I. Milsom and R. Geirsson and F. Skjeldestad},
  journal={Acta Obstetricia et Gynecologica Scandinavica},
  • Ø. Lidegaard, I. Milsom, +1 author F. Skjeldestad
  • Published 2012
  • Medicine
  • Acta Obstetricia et Gynecologica Scandinavica
  • Background. New studies about the influence of hormonal contraception on the risk of venous thromboembolism (VTE) have been published. Aim. To evaluate new epidemiological data and to propose clinical consequences. Design. A literature survey. Methods. Studies assessing the risk of specific types of hormonal contraception were evaluated, compared and set into a clinical perspective. Results. The majority of newer studies have demonstrated a threefold increased risk of VTE in current users of… CONTINUE READING
    57 Citations
    Hormonal contraception, thrombosis and age
    • 30
    Does the Progestogen Used in Combined Hormonal Contraception Affect Venous Thrombosis Risk?
    • L. Han, J. Jensen
    • Medicine
    • Obstetrics and gynecology clinics of North America
    • 2015
    • 16
    • PDF
    Continuous use of oral contraceptives: an overview of effects and side‐effects
    • 20
    Oral contraception in women with mild thrombophilia: what have we learned recently?
    • 8
    Venous thromboembolism in women: a specific reproductive health risk.
    • 58
    • Highly Influenced
    • PDF
    Menopausal hormone therapy and venous thromboembolism
    • M. Bińkowska
    • Medicine
    • Przeglad menopauzalny = Menopause review
    • 2014
    • 4
    • PDF


    Hormonal contraception and risk of venous thromboembolism: national follow-up study
    • 431
    • PDF
    Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study
    • 85
    • Highly Influential
    • PDF
    Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study
    • 104
    • Highly Influential
    • PDF
    The differential risk of oral contraceptives: the impact of full exposure history.
    • 94
    • PDF
    Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs
    • 540
    • PDF